Aptivus

Lea en español

AptivusAptivus is the brand name for Tipranavir, or Tipranavir Disodium, manufactured and marketed by Boehringer-Ingelheim, and used in conjunction with other medications to treat HIV, or human immunodeficiency virus. The drug was first approved by the U.S. Food and Drug Administration (FDA) in 2005.
Tipranavir has been tied to a number of adverse health consequences, from bleeding in the brain and hepatitis to high blood sugar and diabetes. It has also been shown in clinical trials to increase cholesterol levels, as well as triglycerides.
To learn about your rights if you have experienced side effects after using Aptivus, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Avoiding Probate

I often am asked by clients how they can avoid probate. In some situations, it is appropriate to tak…

12 Jul 2019, Friday

What is the Hatch Act and How Did Kellyanne Conway Violate It?

Office of Special Counsel Calls White House Counselor a “Repeat Offender” and Calls for…

25 Jun 2019, Tuesday

TEVA Pharmaceutical Settles Opioid Lawsuit Before Trial

Israeli Drug Company Agrees to Pay $85 Million A second major pharmaceutical company has decided to…

28 May 2019, Tuesday